US2007149488A1PendingUtilityA1

Tetracycline Derivatives and Methods of Use Thereof

Assignee: HLAVKA JOSEPH JPriority: Oct 5, 2001Filed: Feb 27, 2007Published: Jun 28, 2007
Est. expiryOct 5, 2021(expired)· nominal 20-yr term from priority
A61K 31/65C07C 237/26C07C 2603/46A61P 31/04A61P 35/00
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A treatment for inhibiting microbial or tumor growth is disclosed, which comprises adding to a subject in need of treatment an effective amount of one or more tetracycline derivatives.

Claims

exact text as granted — not AI-modified
1 - 6 . (canceled)  
   
   
       7 . A method for treating breast cancer, melanoma, myeloma or prostate cancer, the method comprising: 
 administering a compound or a salt thereof to a subject in need of treatment for a cancer selected from the group consisting of breast cancer, melanoma, myeloma and prostate cancer, the compound being selected from the group consisting of:                          
   
   
       8 . The method of  claim 7 , wherein the administering step comprises administering the compound:  
     
       
         
         
             
             
         
       
     
     or a salt thereof to the subject.  
   
   
       9 . The method of  claim 7 , wherein the administering step comprises administering the compound:  
     
       
         
         
             
             
         
       
     
     or a salt thereof to the subject.  
   
   
       10 . The method of  claim 7 , wherein the administering step comprises administering the compound:  
     
       
         
         
             
             
         
       
     
     or a salt thereof to the subject.  
   
   
       11 . The method of  claim 7 , wherein the administering step comprises administering the compound:  
     
       
         
         
             
             
         
       
     
     or a salt thereof to the subject.

Join the waitlist — get patent alerts

Track US2007149488A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.